The new program serves as a valuable addition to the Company's current portfolio, positioned to target multiple common immuno-inflammatory diseases with the potential to expand access to oral systemic ...

He said: “It is extraordinary that people are able to do multiple jobs like this and reveals the incredible weakness of performance management in these organisations. “If people are able to do ...